<DOC>
	<DOCNO>NCT00587314</DOCNO>
	<brief_summary>To assess effect ablative therapy ( Photodynamic Therapy Radiofrequency ablation ) Barrett 's Esophagus</brief_summary>
	<brief_title>The Effect Ablation Therapy Barrett 's Esophagus</brief_title>
	<detailed_description>To assess effect ablation therapy Barrett 's esophagus . Proposal Ablation therapy FDA approve treatment decrease cancer risk Barrett 's esophagus mucosa . This perform Barrett 's Esophagus Unit regular basis . However , longterm outcome therapy establish patient treat later re-develop Barrett 's mucosa . This study allow u store tissue sample later use assess effect ablative therapy Barrett 's esophagus .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Patients qualify ablation therapy treatment barrett 's esophagus high grade dysplasia early esophageal adenocarcinoma Ability provide inform consent Eastern Cooperative Oncology Group performance status 3 4 Inability tolerate endoscopic procedure Pregnancy : Females childbearing age screen pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Photodynamic Therapy</keyword>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>Early Esophageal Adenocarcinoma</keyword>
</DOC>